- Presentations
- 5
- Markets
- 1
Xofluza is a brand of Baloxavir marboxil marketed by Genentech, with 5 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Baloxavir marboxil
- Brand owner
- Genentech
- Registered in
- United States
- Strengths and forms
- 40 mg/20 mL oral solution, 30 mg oral suspension, 40 mg oral suspension, 40 mg tablet, 80 mg tablet
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Xofluza 40 mg/20 mL oral solutionOral | Genentech | US FDA | Available on request |
| Xofluza 30 mg oral suspensionOral | Genentech | US FDA | Available on request |
| Xofluza 40 mg oral suspensionOral | Genentech | US FDA | Available on request |
| Xofluza 40 mg tabletOral | Genentech | US FDA | Available on request |
| Xofluza 80 mg tabletOral | Genentech | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Xofluza
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.